Welcome to our dedicated page for Neogen SEC filings (Ticker: NEOG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Neogen Corporation (NEOG) SEC filings page provides access to the company’s official regulatory disclosures filed with the U.S. Securities and Exchange Commission. These documents offer detailed insight into Neogen’s operations in food safety, animal safety, and related markets, as well as its governance, compensation practices, and financial condition.
Neogen uses current reports on Form 8-K to disclose material events such as the appointment of a new President and Chief Executive Officer, changes in the Chief Financial Officer role, director retirements and appointments, and the results of shareholder votes at its annual meeting. Filings describe executive compensation arrangements, including base salary, annual bonus targets, long-term equity incentives, and performance share unit programs tied to metrics like revenue growth, adjusted EBITDA margin expansion, and cash flow conversion.
Investors can also review 8-K filings that furnish earnings press releases, which summarize quarterly and annual results, segment performance for Food Safety and Animal Safety, and non-GAAP measures such as adjusted EBITDA. These filings complement the company’s financial statements by providing narrative context and reconciliations.
On Stock Titan, NEOG filings are updated as they are posted to EDGAR, and AI-powered summaries can help explain key elements of lengthy documents, including annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K. Users can quickly identify disclosures related to executive and director changes, incentive plans, shareholder meeting outcomes, and other governance matters.
This page is a resource for understanding how Neogen describes its strategy, risk factors, performance metrics, and capital structure in its own words through formal SEC filings, with tools to make complex regulatory content more accessible.
Neogen Corp (NEOG) reported an insider equity event by a company officer (Former COO). On 10/13/2025, 783 restricted stock units vested and were settled for an equal number of common shares (transaction code M). To satisfy tax withholding, 383 shares were withheld/disposed (code F) at a price listed as $6.04 per share. Following these transactions, the reporting person directly owned 88,858 common shares.
Neogen Corp (NEOG) insider filing reports routine equity compensation activity. An officer (Former CEO) converted 3,063 restricted stock units into common stock on 10/13/2025 (Code M) at $6.04 per share, and recorded a disposition of 865 shares (Code F) at $6.04 per share the same day. After these transactions, the reporting person beneficially owned 332,849 shares, held directly.
The remarks state each RSU is the economic equivalent of one share, and these RSUs vested and were settled for an equal number of common shares on October 13, 2025.
NEOGEN CORP (NEOG) reporting person Amy M. Rocklin had 9,036 restricted stock units vest on 10/07/2025, which were settled for an equal number of shares at a recorded per-share amount of $5.63. The filing also shows a disposition of 3,534 shares on 10/07/2025 at $5.63, leaving the reporting person with 49,672 shares beneficially owned following the transactions. The transactions were signed by an attorney-in-fact on 10/09/2025.
Insider stock vesting and sale by former COO
On 10/07/2025, Douglas Edward Jones, identified as a former COO and officer of Neogen Corp (NEOG), had 12,940 restricted stock units (RSUs) vest and be settled for 12,940 shares of common stock at an indicated per‑share value of $5.63. The Form 4 shows two linked non‑derivative transactions on that date: a grant/settlement code M acquiring 12,940 shares and a disposition code F disposing of 6,329 shares at $5.63. After these reported transactions, Mr. Jones beneficially owned 88,458 shares (direct).
The filing states each RSU equals one share and that vesting and settlement occurred on 10/07/2025. The form is signed by an attorney‑in‑fact on 10/09/2025.
Insider stock activity at NEOGEN (NEOG): Former CEO and officer John Edward Adent had 32,936 restricted stock units vest on 10/07/2025, which were settled into 32,936 shares of common stock at an effective price of $5.63 per share. On the same date, 9,297 shares were disposed of at $5.63, leaving 330,651 shares beneficially owned after the transactions. The filing was signed by an attorney-in-fact on 10/09/2025.
Catherine E. Woteki, a director of NEOGEN CORP (NEOG), had 2,071 restricted stock units vest and be settled into 2,071 shares of common stock on 10/07/2025. The RSUs were settled at a reported per-share value of $5.63, and following the transaction the reporting person beneficially owned 15,315 shares.
The filing is a routine Section 16 Form 4 reporting the vesting and settlement of equity compensation; it shows an increase in the director’s direct holdings but does not disclose any cash sale or purchase beyond the RSU settlement.
Tobin James P, a director of Neogen Corp (NEOG), had 2,071 restricted stock units vest on 10/07/2025 and those RSUs were settled into 2,071 shares of common stock at a recorded price of $5.63 per share. After the settlement, the reporting person beneficially owned 39,545 shares directly. The Form 4 shows this as an acquisition resulting from compensation vesting rather than an open-market purchase.
NEOGEN CORP (NEOG) director Rafael A. Rodriguez received 2,071 restricted stock units that vested and were settled into 2,071 shares of common stock on 10/07/2025. The reported per-share value on the transaction is $5.63, and Mr. Rodriguez's total beneficial ownership after the settlement is 17,019 shares held directly. The filing is a Form 4 disclosure of an insider vesting event rather than a market purchase or sale.
Ashima Gupta, a director of Neogen Corporation (NEOG), reported the vesting and settlement of 2,071 restricted stock units (RSUs) into 2,071 shares of common stock on 10/07/2025. The reported per‑share value recorded on the form is $5.63, and the reporting form shows 23,988 shares beneficially owned by the reporting person following this transaction.
The filing is a routine Section 16 disclosure showing compensation‑related equity vesting rather than an open‑market buy or sell. The form was signed by an attorney‑in‑fact on 10/09/2025.
Neogen Corp director Ronald D. Green had 2,071 restricted stock units (RSUs) vest on 10/07/2025 and those RSUs were settled into an equal number of shares of common stock at an effective price of $5.63 per share. After the settlement, Mr. Green directly owned 14,852 shares. The Form 4 was signed by an attorney-in-fact on 10/09/2025. The filing records a routine equity compensation settlement rather than an open-market purchase or sale.